Objectives-Subjective cognitive complaints in otherwise normal aging are common but may be associated with preclinical Alzheimer Disease in some individuals. Little is known about who is mostly likely to show associations between cognitive complaints and preclinical Alzheimer pathology. We sought to 1) demonstrate associations between subjective complaints and brain amyloid-β in cognitively normal older adults; 2) to explore personality factors as potential moderators of this association.
Objective
Population studies indicate subjective cognitive complaints (SCCs) during aging are a risk factor for cognitive decline and dementia [1] [2] [3] . Neuroimaging studies have reported associations between SCCs and brain signatures of Alzheimer Disease (AD) in otherwise cognitively normal adults, including medial temporal atrophy [4, 5] , reduced glucose metabolism [6, 7] , and amyloid-beta (Aβ) deposition [8] [9] [10] , although not all studies are positive [11] . This emerging literature has prompted interest in subjective cognitive impairment, especially in the absence of objective cognitive deficits, as a putative early neurodegenerative disease stage (i.e., pre-mild cognitive impairment; MCI) and a potential preclinical phase for intervention [12] [13] [14] . That is, the notion that some older individuals may first show insight regarding their own memory changes associated with very early ADpathologic processes, before objectively assessed deficits, has gained recent traction [14] .
However, the reasons that older adults express or endorse subjective cognitive complaints are likely complex and multifactorial. In addition to AD/brain biomarkers and objective cognitive performance, SCCs are associated with individual differences in affective variables, including mood and personality [3, 15] . In particular, two personality factors from the five factor model, high neuroticism and low conscientiousness, are consistent correlates of subjective memory / cognitive complaints [15] [16] [17] . Some authors argue that mood and personality correlates underscore the importance of psychological factors, as opposed to underlying brain dysfunction, in accounting for SCCs in aging [18, 19] . Indeed, in dementia evaluation settings, the term 'worried well' connotes patients who are anxious about memory changes (and perhaps anxious in general) but show no objective findings on exam; the conceptualization reflects a ruling-out of disease by the clinician [20] . Interestingly, however, a separate line of research suggests that personality traits, especially neuroticism, are themselves consistent risk factors and/or disease markers for AD and cognitive decline [21, 22] . Neuroticism is closely related to other negative affect-associated variables, such as risk for depression and vulnerability to stress, which are in turn associated with risk for AD and cognitive decline in aging [23] [24] [25] [26] . To date, relationships among subjectively perceived cognition, personality and AD biomarkers in otherwise healthy older adults are not understood.
The aims of the present study were twofold. First, we examined associations between SCCs and Aβ deposition in cognitively normal older adults. We expected to replicate two previous studies showing association between subjective cognition and presence / degree of Aβ on imaging in CN participants [8, 9] . Secondly, we explored personality factors as potential moderating variables on associations between subjective cognition and Aβ. Regarding neuroticism, specifically, two competing hypotheses were formulated: 1) a 'worried-well' hypothesis would predict SCCs in the context of high neuroticism to be associated with lower risk for biomarker abnormality (i.e., low Aβ). In contrast, 2) an 'negative-affect-risk' hypothesis would predict SCCs in the context of high neuroticism to be associated with higher risk for biomarker abnormality (i.e., high Aβ).
Methods

Participants
Research volunteers for the present study were recruited from two ongoing PiB-PET Imaging studies at the University of Pittsburgh, one of normal aging (n=48) and amyloid and the other focused vascular-amyloid interactions in oldest-old normal aging (n=44). Cognitive classification in both parent studies was based upon a multi-domain neuropsychological assessment and review by a clinical neuropsychologist and/or multidisciplinary consensus diagnostic procedures [27, 28] . Inclusion criteria were normal cognition and age 65 or older. Normal cognition criteria were defined as not more than 1 -2 tests out of the multi-domain battery performed significantly below expectations given an individual's age and educational background (i.e., scores falling more than 1 SD below agecorrected means and taking into account level of education). Exclusion criteria for both parent studies included contraindications for neuroimaging, and history of neurologic, psychiatric or other medical conditions or treatment associated with potentially significant cognitive symptoms. Psychiatric rule-out conditions included current self-reported major depression for both parent studies, and GDS > 15 for the normal aging study. Anxiety disorders were not an exclusion criterion. All participants provided written informed consent and all study procedure were approved by the Institutional Review Board of the University of Pittsburgh. Further details of recruitment and cohort characteristics are provided in Methods, Supplemental Digital Content 1.
Self-report behavioral assessments
Self-report questionnaires were administered at the time of PiB-PET imaging. Personality traits were assessed with the NEO Five-Factor Inventory (FFI-3), a 60 item questionnaire measuring the domains neuroticism, consciousness, extraversion, agreeableness, and openness-to-experience [29] . These domains reflect the five-factor model, an empirically derived structure with broad scientific consensus regarding covariation of personality traits across cultures and human development. Raw NEO-FFI scores were converted to standardized T-scores (mean 50, SD 10) according to test manual norms and procedures. Subjective cognitive complaints were assessed with the 64-item Memory Functioning Questionnaire (MFQ) [30] ; the 25-item Cognitive Failures Questionnaire (CFQ) [31] ; and a 24-item subjective cognitive complaints scale (SCCS) [32] . Depressive symptoms were measured with the 30-item Geriatric Depression Scale (GDS) [33] .
Neuroimaging
[11C]PiB was produced as previously described [34] . Prior to PiB-PET, a 1.5 or 3T spoiledgradient-recalled-MR was obtained for each subject for co-registration and region-of-interest (ROI) definition [34] . PET imaging was conducted using a Siemens/CTI ECAT HR + (3D mode, 15.2 cm field-of-view, 63 planes, reconstructed image resolution ~ 6 mm FWHM). The participant's head was immobilized to minimize head motion. PiB was injected intravenously (12-15 mCi, over 20 s, specific activity ~ 1-2 Ci/μmol) and PET scanning was performed at least 50-70 min post injection. Analysis of the PiB PET data utilized standardized uptake value ratio (SUVR) (determined 50-70 min post-injection). To calculate SUVR, SUV was first determined by normalizing regional tissue radioactivity concentration to injected dose and body mass, and then each regional SUV was divided by the cerebellar reference SUV that was representative of free and nonspecific radiotracer retention.
PiB retention was quantified with a global SUVR score, the average of five cortical regions (precuneus, anterior cingulate, frontal, parietal, lateral temporal) and the striatum.
White matter hyperintensities (WMH) were included as a measure of sub-clinical cerebrovascular disease burden. WMH volume was obtained from T2-weighted FLAIR images, as previously described [35] . FLAIR images were acquired in the axial plane: TR=9160 ms; TE=90 ms; TI=2500 ms; FA=150 deg; FOV= 256*212 mm; slice thickness=3 mm; matrix size=256*212; number of slices=48 slices; and voxel size= 1 mm*1 mm*3 mm. The WMH quantification was done using a fuzzy connected algorithm [35] . The total WMH volume was normalized for brain volume.
Analysis
Primary analyses evaluated subjective cognition -Aβ associations. As a first step, we computed bivariate Pearson correlations among behavioral self-report measures, global PiB retention and key demographic/ clinical variables to guide inclusion of covariates in subsequent linear regression models. We then evaluated subjective cognition -Aβ associations with linear regression models, in which each subjective cognitive complaint questionnaire was modeled independently from the others, adjusting for age, sex, and depressive symptoms with global PiB retention as the outcome (3 subjective cognition total score measures plus 4 MFQ factor scores = 7 models). We did not include APOE*4 allele carrier status in the primary analyses because of the small number in the sample (n=14), and also because of the high degree of overlap between APOE*4 and Aβ [36] . However, secondary analyses were conducted including APOE*4 in relevant models and reported for comparison.
All correlation p-values evaluated and reported are two-tailed.
To evaluate personality factors as potential moderators of subjective cognition -Aβ associations, we created dichotomous groupings by median splits on subjective cognitive complaint measures (i.e., low vs. high subjective complaints) as well as personality measures (e.g., low vs. high neuroticism). These dichotomized variables were entered as main effects in ANOVA models, and each model included a two-way SCC × personality interaction term (the 3 subjective cognition total score measures × 5 personality measure = 15 ANOVA interaction models), with global PiB SUVR as the outcome, adjusting for age, sex and depression score. Because of the multitude of independent models uncorrected (p < . 05) for multiple comparisons, these interaction models were considered exploratory.
Analyses were conducted using SPSS v. 20 and SAS 9.4. Table 1 presents descriptive characteristics, mean behavioral self-report scores and global PiB SUVR for the 92 participants. Several self-report measures had limited missing data due to date collection lags and incomplete assessments, with the maximum missing on the SCCS (n=10). Of note, the sample was somewhat older than typical neuroimaging studies of aging, with a mean age of 81 and IQR of 74 to 87 years. Mean personality factor scores were comparable to other published reports of older adults without dementia [37] . Mean subjective cognitive complaint scores were also comparable to published older adult community samples for the three subjective cognition measures (MFQ [38] ; CFQ [39] ; SCCS [32] ).
Results
White matter hyperintensities were available in a subset of n=66 participants, due to changes in data pre-processing and technical issues (e.g., motion artifact).
Bivariate correlations among key variables
We examined zero-order correlations among self-report measures, age, education and global PiB SUVR (see Table, 
Subjective cognition -Aβ associations
Regression models were run to investigate whether subjective cognitive complaints predicted global PiB SUVR, adjusting for age, sex and depressive symptoms. Worse subjective cognition on the MFQ (total score) was associated with higher global PiB retention, with the full model results summarized in Table 2a . Neither the CFQ nor the SCCS were associated with PiB retention (see Table, Supplemental Digital Content 3, summarizing regression coefficients from adjusted models for SCC scales). Among the MFQ factor sub-scales, the General Frequency of Forgetting factor was associated with PiB retention (Table 2b) .
Subjective cognition, WMH, and number of medications
There were no significant correlations between WMH and any of the key study measures of subjective cognition, personality and Aβ deposition. Similarly, there were no significant correlations between current number of medications, subjective cognition, personality, or Aβ deposition.
Role of APOE*4 allele
Being a carrier of at least one APOE* 
Exploratory analyses of personality as mediator
Results from the ANOVA models evaluating potential subjective cognitive complaints × personality interactions indicated one significant interaction term in the MFQ × neuroticism model ( Table 3 ). In that model, age was the only significant main effect (Table 3 ). Figure 1 illustrates the nature of the MFQ × neuroticism interaction: the expected association between cognitive complaints (scaled for the figure such that higher scores correspond to more symptoms, consistent with neuroticism) and global PiB retention is apparent among the high-neuroticism group.
Associations between subjective and objective cognition
Among bivariate correlations between the neuropsychological measures reported in Table 1 
Conclusions
The goals of this study were twofold. The first goal was to replicate recent findings that subjective cognition was associated with Aβ imaging in cognitively normal older adults. We observed this association for one of three different questionnaire measures of SCCs, while controlling for demographic variables and concurrent depressive symptoms. Thus, evidence to date for subjective cognition -amyloid associations in healthy older individuals is demonstrable but limited, i.e., not observed consistently across multiple SCC measures. In the Perrotin et al. study [8] , as well, only one of 10 metacognition ratings ("general memory compared to others of the same age") significantly differed between PiB-positive (n=11) and PiB-negative (n=28) in a smaller sample of normal volunteers. In the Amariglio et al. study [9] , a subjective memory complaint composite score was generated to evaluate a memoryfocused hypothesis; but of the 11 subjective cognition sub-scales reported, 3 were associated with Aβ deposition in a larger cognitively normal sample (n=131). It may be that the overall effect is small and variable among measures and samples in a non-reliable manner. Alternatively, there may be specific self-report scales that are reliably more likely to show associations with Aβ deposition / AD biomarkers, whether for psychometric-or item content-related reasons, or both. It is noteworthy that the MFQ factor General Frequency of Forgetting factor, and not the other three MFQ factors, showed a significant association in our study, as well as in the Amariglio study. This same MFQ factor pattern of association was also reported in a third imaging study [40] using [F-18] FDDNP, a less specific PET tracer reflecting Aβ as well as tau neurofibrillary tangle load in cognitively normal and MCI participants combined. We suggest the MFQ General Frequency of Forgetting factor, a 33-item sub-scale reflecting perceived frequency of memory failures in a variety of specific situations (e.g., names, faces, appointments, etc.), may be a useful candidate measure for further study in relation to preclinical AD biomarkers. Of note, none of the subjective cognition measures were related to WMH or to number of medications, as a proxy for overall health.
The second study goal was to explore five factor model personality measures as potential moderators of SCC -Aβ associations. Two factors, neuroticism and conscientiousness, are consistent correlates in the literature both of SCCs and of risk for AD / dementia / cognitive decline. Of the two, neuroticism is the mostly widely reported correlate. We observed a significant interaction between neuroticism and subjective cognition (MFQ only), such that subjective memory in the context of higher neuroticism showed the predicted association with global Aβ deposition. Individuals with poor subjective memory and high neuroticism had highest mean Aβ on imaging. No other personality factors were significant moderators.
The observed interaction is consistent with an 'negative-affect-risk' model of how neuroticism may relate to markers of AD risk, including subjective memory complaints. That is, both poorer cognitive self-appraisal and greater tendency toward psychological distress reflect facets of negative affect, which in turn may be generally related to dementia risk [21, 22, 25, 26, 41, 42] . Possible mechanisms include links between chronic stress and CNS alterations along the limbic (particularly hippocampal) -hypothalamic -pituitaryadrenal axis [43, 44] ; risk for cardiovascular disease [45] , in turn a significant risk factor for dementia; and neuroticism-associated brain structure variation in normal aging, including smaller global grey matter and regional frontal volumes [46] . As well, a direct association between neuroticism and spread of tangle pathology in limbic and neocortical regions on autopsy has been reported [47] . Finally, of note, a recent study similarly reported a moderating effect of neuroticism on the association between APOE*4 allele and both cognitive decline and incident AD [48] .
In contrast to the 'negative-affect-risk' model, we described an alternative 'worried well' model which reflects the clinical notion that worry in otherwise high functioning older memory complainers is a good prognostic sign, and signals lower risk for 'true' (i.e., neurologic) disease. This model was not supported by our data. Our findings may also be generally consistent with evidence that cognitive complaints associated with "worry" (compared to cognitive complaints without significant worry) is more predictive of incident AD over three years among older primary care patients [1] . In the present study, however, we did not address specific worry about everyday memory functioning. We also note that the constructs 'worry' and 'neuroticism' have been shown to be distinct from each other, although correlated, in younger populations [49] . In the present study, as operationalized by scores on trait neuroticism, we observed that the tendency to toward higher emotional instability was a higher risk-state for poorer subjective cognition being associated with AD pathology. This interaction is also consistent with the notion that individuals high on neuroticism may be more likely to be perceptive of, or sensitive to, somatic symptoms in general [50] and/or to subtle changes in everyday cognitive functioning over time, specifically.
There are several limitations of the present study to note. First, clinical anxiety disorders were not assessed. While we expect the rate to be relatively low in this selected and generally healthy volunteer sample, analyses were not controlled for such conditions and we do not know the potential role they may have played. Second, the relatively older mean age of the sample (81 years) may constrain generalizability to other younger-elderly populations. An important consequence of older age distribution is the high degree of Aβ deposition [36] .
In absence of frank clinical deficits (by selection) in participants surviving and thriving into the 9 th decade of life, any effect of highly prevalent Aβ deposition at this age may be different, presumably attenuated, compared to a younger age [51, 52] . Future studies with larger samples are needed to compare age-specific effects. We note that the three subjective cognition measures were associated with several objective cognitive measures in the expected directions, supporting their validity in this sample. Regarding Five-Factor personality measurements in the oldest-old, these have been investigated and validated previously [53, 54] . Longitudinal studies of aging over 60 on personality traits indicate mean-level changes on Five Factor traits, including mean decrease in neuroticism, but rankorder consistency [55, 56] . This latter point supports validity of these measure in the present study.
A major limitation to note is the large number of secondary and exploratory significance tests conducted without adjustment for multiple comparisons, with consequently an increased risk of Type I error. The subjective cognition -personality interaction models were considered exploratory and the significant finding with neuroticism warrants independent replication. In sum, we observed an association between the Memory Functioning Questionnaire ratings and global Aβ deposition in cognitively normal older neuroimaging study volunteers. We observed suggestive evidence that trait neuroticism moderated this association such that it was stronger among high-compared to low-neuroticism individuals. These findings are relevant to an evolving research interest in subjective cognitive decline as a potentially meaningful pre-MCI stage. To date, clinicians and researchers lack informative data addressing multiple etiologies of subjective cognitive complaints and the complexities of cognitive self-appraisal in aging. Individual differences in personality and affective variables may serve to better define the phenotype of subjective cognitive decline associated with an underlying neurodegenerative process.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Interaction between neuroticism and subjective cognitive complaints on global PiB retention. A). Distributions by box-plot of global PiB retention by subjective cognitive complaints and neuroticism groups (low vs high by median split on each measure). Subjective cognition was measured by the MFQ, which was reverse-scaled for this figure only to reflect low vs high level of complaints (for consistency with neuroticism scaling). B) Estimated means of global PiB SUVR from the interaction model in Table 3 (adjusted for age, sex and GDS score), showing higher PiB retention associated with poorer subjective cognition only among participants with higher neuroticism scores. 
